ICU Meningitis and Encephalitis: Time-Critical Antimicrobials and ICP Control
This narrative review consolidates evidence-based pharmacotherapy and intracranial pressure strategies that frame the ICU pharmacist's role in rapid, pathogen-directed management of central nervous system (CNS) infections.
Meningitis and encephalitis require urgent ICU management due to potential severe complications. Early antimicrobial treatment with optional adjuvant steroids improves outcomes; manage seizures, intracranial pressure, and potential neurosurgical needs. Ensures ICU teams prioritize quick diagnosis, appropriate interventions, and manage complications effectively. Swift, targeted ICU interventions can save lives in meningitis and encephalitis cases.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Citation:Marquez D, Dangayach NS Intensive Care Unit Management of Meningitis and Encephalitis. Critical care clinics. 2026;42(3):481-498. doi:10.1016/j.ccc.2026.01.006
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.